ACE-i, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor antagonist; CABG, coronary artery bypass grafting; CKD, chronic kidney disease; PCI, percutaneous coronary intervention; NOAC, novel oral anticoagulant; NYHA, New York Heart Association; TIA, transient ischemic attack. This evidence concerns the gene ACE and chronic kidney disease.